CVAC
Price
$3.53
Change
+$0.06 (+1.73%)
Updated
Apr 29 closing price
Capitalization
781.29M
21 days until earnings call
MRNA
Price
$27.82
Change
+$0.36 (+1.31%)
Updated
Apr 29 closing price
Capitalization
10.62B
One day until earnings call
Ad is loading...

CVAC vs MRNA

Header iconCVAC vs MRNA Comparison
Open Charts CVAC vs MRNABanner chart's image
CureVac
Price$3.53
Change+$0.06 (+1.73%)
Volume$928.51K
Capitalization781.29M
Moderna
Price$27.82
Change+$0.36 (+1.31%)
Volume$5.24M
Capitalization10.62B
CVAC vs MRNA Comparison Chart
Loading...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVAC vs. MRNA commentary
Apr 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVAC is a Buy and MRNA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 30, 2025
Stock price -- (CVAC: $3.53 vs. MRNA: $27.82)
Brand notoriety: CVAC: Not notable vs. MRNA: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVAC: 150% vs. MRNA: 55%
Market capitalization -- CVAC: $781.29M vs. MRNA: $10.62B
CVAC [@Biotechnology] is valued at $781.29M. MRNA’s [@Biotechnology] market capitalization is $10.62B. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVAC’s FA Score shows that 0 FA rating(s) are green whileMRNA’s FA Score has 1 green FA rating(s).

  • CVAC’s FA Score: 0 green, 5 red.
  • MRNA’s FA Score: 1 green, 4 red.
According to our system of comparison, CVAC is a better buy in the long-term than MRNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVAC’s TA Score shows that 5 TA indicator(s) are bullish while MRNA’s TA Score has 5 bullish TA indicator(s).

  • CVAC’s TA Score: 5 bullish, 6 bearish.
  • MRNA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, MRNA is a better buy in the short-term than CVAC.

Price Growth

CVAC (@Biotechnology) experienced а +10.66% price change this week, while MRNA (@Biotechnology) price change was +8.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.83%. For the same industry, the average monthly price growth was -2.17%, and the average quarterly price growth was -9.97%.

Reported Earning Dates

CVAC is expected to report earnings on Aug 14, 2025.

MRNA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+3.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRNA($10.6B) has a higher market cap than CVAC($781M). CVAC YTD gains are higher at: 3.519 vs. MRNA (-33.093). CVAC has higher annual earnings (EBITDA): 166M vs. MRNA (-3.39B). MRNA has more cash in the bank: 7.03B vs. CVAC (555M). CVAC has less debt than MRNA: CVAC (40.1M) vs MRNA (747M). MRNA has higher revenues than CVAC: MRNA (3.2B) vs CVAC (543M).
CVACMRNACVAC / MRNA
Capitalization781M10.6B7%
EBITDA166M-3.39B-5%
Gain YTD3.519-33.093-11%
P/E Ratio4.22N/A-
Revenue543M3.2B17%
Total Cash555M7.03B8%
Total Debt40.1M747M5%
FUNDAMENTALS RATINGS
MRNA: Fundamental Ratings
MRNA
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CVACMRNA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 13 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ASG4.870.07
+1.46%
Liberty All-Star Growth FD
QGRW45.040.29
+0.65%
WisdomTree U.S. Quality Growth ETF
XB39.030.05
+0.13%
BondBloxx B Rated USD Hi Yld Corp Bd ETF
VGSH58.890.03
+0.05%
Vanguard Short-Term Treasury ETF
CHN12.00-0.12
-0.99%
China Fund

CVAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVAC has been loosely correlated with BNTX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CVAC jumps, then BNTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVAC
1D Price
Change %
CVAC100%
+1.73%
BNTX - CVAC
46%
Loosely correlated
N/A
MRNA - CVAC
45%
Loosely correlated
+1.31%
MDGL - CVAC
42%
Loosely correlated
+2.87%
ARCT - CVAC
41%
Loosely correlated
N/A
AXON - CVAC
39%
Loosely correlated
+1.44%
More

MRNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRNA has been loosely correlated with BNTX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MRNA jumps, then BNTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRNA
1D Price
Change %
MRNA100%
+1.31%
BNTX - MRNA
51%
Loosely correlated
N/A
RCKT - MRNA
51%
Loosely correlated
+1.68%
CVAC - MRNA
45%
Loosely correlated
+1.73%
CRSP - MRNA
43%
Loosely correlated
-1.27%
RXRX - MRNA
42%
Loosely correlated
-2.05%
More